Get the latest updates on the potential collaboration between director Sandeep Reddy Vanga and Tollywood star Ram Charan for a new film. Discover the details about Vanga's upcoming projects and ...

Balmuri said that the comments against Revanth Reddy would create a law and order problem in the state. He demanded action against KTR for making unwarranted comments against the CM ...

In England, though, Reddy faces a number of challenges, which include the pitch, overhead conditions, and the wobble seam, all of which can only be addressed with good defensive technique.

Unveiling of Anam Venkata Reddy's bronze statue celebrated, highlighting his political legacy and contributions to Nellore's development.

Dr. Reddy's Laboratories and Alvotech have partnered to co-develop, manufacture, and commercialize a biosimilar of Keytruda (pembrolizumab), a significant cancer treatment.

Dr. Reddy's and Alvotech collaborate to develop biosimilar to Keytruda, enhancing oncology capabilities and global reach.

LIC’s shareholding in Dr. Reddy’s Laboratories rose from 5.6% at the end of September 2024 to 6.5% by December 2024, and further to 7.19% as of March 2025, according to the latest shareholding ...

Dr Reddy’s Laboratories announced that it has partnered with Alvotech, to co-develop, manufacture, and sell a biosimilar version of Keytruda (pembrolizumab), for global markets.

When Sandeep Reddy Vanga wasn’t convinced with Ranbir Kapoor’s look in Animal In the interview, Aalim revealed that Sandeep took some convincing to let Ranbir have long hair and a beard in Animal.

Shares of Dr. Reddy’s Laboratories surged 4 percent to Rs 1,303 on June 5, making it one of the top gainers on the Nifty 50. The rally followed the company’s announcement of a strategic ...

The collaboration combines Dr. Reddy’s and Alvotech’s proven capabilities in biosimilars, thereby, speeding up the development process and extending the global reach for this biosimilar candidate.